1wzy
Crystal structure of human ERK2 complexed with a pyrazolopyridazine derivativeCrystal structure of human ERK2 complexed with a pyrazolopyridazine derivative
Structural highlights
Evolutionary Conservation![]() Check, as determined by ConSurfDB. You may read the explanation of the method and the full data available from ConSurf. Publication Abstract from PubMedA series of pyrazolopyridazine compounds were briefly investigated as ERK2 inhibitors. The crystal structure of ERK2 complexed with an allyl derivative was determined. The compound induces structural change including movement of the glycine-rich loop and peptide flip between Met108-Glu109. As a result, the newly formed subsite can recognize small hydrophobic substituents but not hydrophilic ones. Crystal structure of human ERK2 complexed with a pyrazolo[3,4-c]pyridazine derivative.,Kinoshita T, Warizaya M, Ohori M, Sato K, Neya M, Fujii T Bioorg Med Chem Lett. 2006 Jan 1;16(1):55-8. Epub 2005 Oct 18. PMID:16242327[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
|